10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management ...
The Harvard Crimson9h
Harvard, 10x Genomics Settle Patent Dispute With Vizgen
Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...
Analysts Set 10x Genomics, Inc. (NASDAQ:TXG) Target Price at $20.57
Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received a consensus recommendation of “Hold” from the seventeen analysts ...
10x Genomics (TXG) Receives a Buy from Morgan Stanley
Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...
10x Genomics price target lowered to $15 from $18 at Barclays
Barclays lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps an Overweight rating on the shares.Maximize Your ...
10x Genomics (NASDAQ:TXG) Cut to “Hold” at Leerink Partnrs
Leerink Partnrs downgraded shares of 10x Genomics (NASDAQ:TXG – Free Report) from a strong-buy rating to a hold rating in a ...
The Victoria Advocate5d
10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
PLEASANTON, Calif., Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will ...
Benzinga.com9d
Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties
10x Genomics posted a Q4 EPS loss of $(0.40), missing the $(0.30) estimate. The company’s 2025 sales guidance of $610M-$630M is below the $631.14M consensus. Get two weeks of free access to pro ...